• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lexicon Pharmaceutcl (NQ: LXRX )

    1.175 -0.775 (-39.74%)
    Streaming Delayed Price Updated: 9:48 AM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Lexicon Pharmaceutcl

    < Previous 1 2 3 4 5 6 Next >
    Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
    Lexicon Pharmaceuticals' sotagliflozin, under review as an adjunct to insulin for type 1 diabetes and CKD, faced an FDA panel vote against approval, with mixed expert support. 
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)
    Via Benzinga
    Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock
    Via Benzinga
    The Analyst Verdict: Lexicon Pharmaceuticals In The Eyes Of 8 Experts
    Via Benzinga
    Analyst Scoreboard: 6 Ratings For Lexicon Pharmaceuticals
    Via Benzinga
    Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights
    Via Benzinga
    5 Analysts Have This To Say About Lexicon Pharmaceuticals
    Via Benzinga
    Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Intel Reports Weak Results, Joins Amazon, Opendoor Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Lexicon Pharmaceuticals: Q4 Earnings Insights
    Via Benzinga
    Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM. 
    Via Investor's Business Daily
    LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024
    LXRX stock results show that Lexicon Pharmaceuticals met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday. 
    Via Benzinga
    Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. 
    Via Benzinga
    Dow Turns Higher; GDS Holdings Shares Climb
    U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
    U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&P 500... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
    Via Benzinga
    Exposures Product Safety
    Top 4 Health Care Stocks You May Want To Dump In February
    As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
    Via Benzinga
    3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts
    If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year. 
    Via The Motley Fool
    Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. 
    Via Benzinga
    3 of the Fastest-Growing Stocks on the Planet in 2024
    These hypergrowth stocks are expected to deliver sales growth of up to 1,106% in the new year. 
    Via The Motley Fool
    7 Magnificent Stocks That Can Double Your Money in 2024
    Triple-digit returns could be just a click of the buy button away. 
    Via The Motley Fool
    3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
    Wall Street analysts foresee up to 316% upside in three fast-paced companies in the new year. 
    Via The Motley Fool
    Insiders Buying Blend Labs And 3 Other Stocks Under $2
    The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.